Publikationen, an denen er mitarbeitet Carlos González Juanatey (13)

2023

  1. The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis

    Medicine, Vol. 102, Núm. 29, pp. e34322

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2017

  1. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up

    Heart and Vessels, Vol. 32, Núm. 9, pp. 1077-1084

  2. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2003

  1. Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: Clinical and morphological characteristics of 20 cases and review of the literature

    Canadian Journal of Cardiology, Vol. 19, Núm. 10, pp. 1139-1145

2002

  1. Pneumopericardium complicating bronchogenic carcinoma

    Revista Espanola de Cardiologia, Vol. 55, Núm. 2, pp. 185

2001

  1. Rheumatic manifestations of infective endocarditis in non-addicts: A 12-year study

    Medicine, Vol. 80, Núm. 1, pp. 9-19

1999

  1. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril

    American Journal of Cardiology, Vol. 83, Núm. 5, pp. 719-723

  2. Step-down of enalapril treatment for arterial hypertension

    Hypertension, Vol. 34, Núm. 6, pp. 1287-1292

  3. Ventricular function following drug-induced regression of hypertensive left ventricular hypertrophy

    Congestive Heart Failure, Vol. 5, Núm. 2, pp. 77-80+85

1998

  1. Using low doses of enalapril maintains the reduction of QT and QTc dispersion achieved by prolonged treatment with higher doses

    Journal of Noninvasive Cardiology, Vol. 2, Núm. 6, pp. 28-34